WASHINGTON, January 25, 2005 (LifeSiteNews.com) – The US Food and Drug Administration has announced a delay in deciding whether to license the abortifacient morning-after pill for over-the-counter sales. Co-sponsors of the morning-after pill’s development, New York’s Center for Reproductive Rights (CRR) filed a lawsuit against the FDA within hours of hearing news of the delay.
This marks the second such application launched by Plan B’s manufacturer, Barr Laboratories. The FDA denied their first attempt at over-the-counter saying they would reconsider Barr’s request if the company restricted sales of the chemical abortifacient to girls age 16 and older.
Approving Plan B for over-the counter sales “encourages risky sexual activity with the promise ‘just pop a pill in the morning and you don’t need to worry about pregnancy,’” warned Concerned Women of America spokeswoman Wendy Wright.
tv